- Home
- STEP vs PTCT Comparison
STEP vs PTCT Comparison
Compare STEP & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEP
- PTCT
- Stock Information
- Founded
- STEP 2007
- PTCT 1998
- Country
- STEP United States
- PTCT United States
- Employees
- STEP N/A
- PTCT N/A
- Industry
- STEP Finance/Investors Services
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- STEP Finance
- PTCT Health Care
- Exchange
- STEP Nasdaq
- PTCT Nasdaq
- Market Cap
- STEP 4.6B
- PTCT 3.7B
- IPO Year
- STEP 2020
- PTCT 2013
- Fundamental
- Price
- STEP $53.04
- PTCT $50.34
- Analyst Decision
- STEP Buy
- PTCT Buy
- Analyst Count
- STEP 7
- PTCT 14
- Target Price
- STEP $65.14
- PTCT $63.57
- AVG Volume (30 Days)
- STEP 791.2K
- PTCT 1.1M
- Earning Date
- STEP 08-07-2025
- PTCT 08-07-2025
- Dividend Yield
- STEP 2.56%
- PTCT N/A
- EPS Growth
- STEP N/A
- PTCT N/A
- EPS
- STEP N/A
- PTCT 7.51
- Revenue
- STEP $1,174,830,000.00
- PTCT $1,772,758,000.00
- Revenue This Year
- STEP N/A
- PTCT $121.50
- Revenue Next Year
- STEP $21.23
- PTCT N/A
- P/E Ratio
- STEP N/A
- PTCT $6.68
- Revenue Growth
- STEP 65.09
- PTCT 91.12
- 52 Week Low
- STEP $40.07
- PTCT $28.72
- 52 Week High
- STEP $70.38
- PTCT $58.38
- Technical
- Relative Strength Index (RSI)
- STEP 39.03
- PTCT 54.78
- Support Level
- STEP $51.80
- PTCT $49.47
- Resistance Level
- STEP $54.39
- PTCT $52.45
- Average True Range (ATR)
- STEP 1.59
- PTCT 1.54
- MACD
- STEP -0.75
- PTCT -0.09
- Stochastic Oscillator
- STEP 17.87
- PTCT 49.17
About STEP StepStone Group Inc.
StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.